Bio-Techne Corp (TECH): Price and Financial Metrics


Bio-Techne Corp (TECH): $338.97

2.65 (+0.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TECH to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TECH POWR Grades

  • TECH scores best on the Quality dimension, with a Quality rank ahead of 92.43% of US stocks.
  • TECH's strongest trending metric is Growth; it's been moving down over the last 179 days.
  • TECH ranks lowest in Momentum; there it ranks in the 10th percentile.

TECH Stock Summary

  • With a price/earnings ratio of 47.35, BIO-TECHNE CORP P/E ratio is greater than that of about 87.61% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for BIO-TECHNE CORP is higher than 88.9% of stocks in our set with a positive cash flow.
  • TECH's price/sales ratio is 12.37; that's higher than the P/S ratio of 91.06% of US stocks.
  • Stocks that are quantitatively similar to TECH, based on their financial statements, market capitalization, and price volatility, are LNTH, HZNP, RGEN, APPS, and OMCL.
  • TECH's SEC filings can be seen here. And to visit BIO-TECHNE CORP's official web site, go to www.bio-techne.com.

TECH Valuation Summary

  • TECH's price/sales ratio is 11; this is 478.95% higher than that of the median Healthcare stock.
  • Over the past 243 months, TECH's price/earnings ratio has gone down 4.2.

Below are key valuation metrics over time for TECH.

Stock Date P/S P/B P/E EV/EBIT
TECH 2022-11-01 11.0 7.1 44.6 38.2
TECH 2022-10-31 10.5 6.8 42.7 36.6
TECH 2022-10-28 10.5 6.8 42.6 36.5
TECH 2022-10-27 10.5 6.8 42.6 36.5
TECH 2022-10-26 10.7 7.0 43.5 37.3
TECH 2022-10-25 10.5 6.8 42.8 36.6

TECH Growth Metrics

    The 3 year net cashflow from operations growth rate now stands at 80.87%.
  • Its 2 year cash and equivalents growth rate is now at 2.95%.
  • Its year over year net income to common stockholders growth rate is now at 22.35%.
Over the past 37 months, TECH's revenue has gone up $383,256,000.

The table below shows TECH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,117.535 332.919 291.991
2022-06-30 1,105.599 325.272 272.051
2022-03-31 1,076.399 344.575 225.487
2021-12-31 1,029.575 346.313 210.53
2021-09-30 984.552 334.589 176.631
2021-06-30 931.032 352.164 140.41

TECH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TECH has a Quality Grade of B, ranking ahead of 82.49% of graded US stocks.
  • TECH's asset turnover comes in at 0.44 -- ranking 101st of 682 Pharmaceutical Products stocks.
  • URGN, TMBR, and CRIS are the stocks whose asset turnover ratios are most correlated with TECH.

The table below shows TECH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.440 0.680 0.188
2021-03-31 0.412 0.673 0.250
2020-12-31 0.392 0.666 0.240
2020-09-30 0.376 0.662 0.330
2020-06-30 0.372 0.654 0.302
2020-03-31 0.387 0.660 0.271

TECH Price Target

For more insight on analysts targets of TECH, see our TECH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $549.60 Average Broker Recommendation 1.36 (Strong Buy)

TECH Stock Price Chart Interactive Chart >

Price chart for TECH

TECH Price/Volume Stats

Current price $338.97 52-week high $522.96
Prev. close $336.32 52-week low $272.01
Day low $334.74 Volume 114,100
Day high $343.10 Avg. volume 266,367
50-day MA $305.38 Dividend yield 0.38%
200-day MA $360.42 Market Cap 13.30B

Bio-Techne Corp (TECH) Company Bio


Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. The company was founded in 1976 and is based in Minneapolis, Minnesota.


TECH Latest News Stream


Event/Time News Detail
Loading, please wait...

TECH Latest Social Stream


Loading social stream, please wait...

View Full TECH Social Stream

Latest TECH News From Around the Web

Below are the latest news stories about BIO-TECHNE CORP that investors may wish to consider to help them evaluate TECH as an investment opportunity.

NAMOCELL HIGHLIGHTED IN NATURE PUBLICATION FOR EFFICIENT SINGLE CELL CLONING OF HUMAN PLURIPOTENT STEM CELLS

Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a single-cell cloning workflow study using the Namocell™ Single Cell Dispenser in Nature Protocols: Efficient and safe single-cell cloning of human pluripotent stem cells using the chroman 1, emricasan, polyamines, and trans-ISRIB (CEPT) cocktail. This publication outlines a robust and scalable workflow for cloning human pluripotent stem cells (hPSCs) that maximizes the viability of the cells using the Namocell Single Cell

Yahoo | November 17, 2022

BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY

Bio-Techne Corporation (NASDAQ: TECH) today announced the opening of its new 52,000 square foot state-of-the-art product innovation and manufacturing facility. The expansion more than doubles the operational footprint at Bio-Techne's Wallingford, Connecticut site and provides a five-fold increase in Ella™ immunoassay cartridge production capacity. Ella is an automated multiplexing immunoassay system, that enables rapid and hands-free precision biomarker detection.

Yahoo | November 15, 2022

BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE

Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Stephens Annual Investment Conference on Thursday, November 17, 2022, at 10:00 a.m. CST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

Yahoo | November 10, 2022

BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE

Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022, at 2:25 p.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

Yahoo | November 8, 2022

BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Credit Suisse 31st Annual Healthcare Conference on Wednesday, November 9, 2022, at 8:35 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

Yahoo | November 3, 2022

Read More 'TECH' Stories Here

TECH Price Returns

1-mo 14.94%
3-mo 1.87%
6-mo -8.06%
1-year -28.08%
3-year 54.61%
5-year 161.61%
YTD -34.18%
2021 63.40%
2020 45.40%
2019 52.67%
2018 12.60%
2017 27.40%

TECH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TECH Dividend History

Continue Researching TECH

Want to see what other sources are saying about BIO-TECHNE Corp's financials and stock price? Try the links below:

BIO-TECHNE Corp (TECH) Stock Price | Nasdaq
BIO-TECHNE Corp (TECH) Stock Quote, History and News - Yahoo Finance
BIO-TECHNE Corp (TECH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7008 seconds.